FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2-induced resistance
- DOI
- 10.1186/s12943-015-0362-9
- Published
- 2015-04-28
- Container
- Molecular Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12943-015-0362-9,
title = {FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2-induced resistance},
author = {David Westover and Xiang Ling and Hong Lam and Jacob Welch and Chunyang Jin and Celine Gongora and Maguy Del Rio and Mansukh Wani and Fengzhi Li},
year = {2015},
journal = {Molecular Cancer},
doi = {10.1186/s12943-015-0362-9},
url = {https://doi.org/10.1186/s12943-015-0362-9}
}RIS
TY - JOUR TI - FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2-induced resistance AU - David Westover AU - Xiang Ling AU - Hong Lam AU - Jacob Welch AU - Chunyang Jin AU - Celine Gongora AU - Maguy Del Rio AU - Mansukh Wani AU - Fengzhi Li PY - 2015 JO - Molecular Cancer DO - 10.1186/s12943-015-0362-9 UR - https://doi.org/10.1186/s12943-015-0362-9 ER -
APA
Westover, D., Ling, X., Lam, H., Welch, J., Jin, C., Gongora, C., Rio, M. D., Wani, M., & Li, F. (2015). FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2-induced resistance. Molecular Cancer. https://doi.org/10.1186/s12943-015-0362-9
Source records
- crossref · retrieved 2026-11-10T12:39:09.651Z